User Name Password Remember Me
 
 
   
Video Podcast
Audio Cast
Mobile(WAP)
  Pedi Poll  
Should HIV testing be done only after informed written consent_?
Yes
No
  Translate This Page  
 
HYPER IGM WITH RECURRENT NEONATAL INFECTIONS
Dr Ira Shah
M.D, DNB, DCH(Gold Medalist), FCPS

Case Report


A 3 days old male child born of third degree consanguineous marriage presented with anuria since 24 hours and lethargy since 6 hours. He was a full term emergency LSCS delivery in view of pregnancy induced hypertension in mother. There was no history of maternal drug ingestion or maternal fever antenatally. His birth weight was 3.3 kg and he had a weak cry at birth. He received 2 blood transfusions after birth for pallor. On examination, his weight was 3.3 kg with a height of 48 cms and head circumference of 36.5 cms. There were no dysmorphic features and vital parameters were normal. He had no hypertension and systemic examination was normal. He was given a challenge of 20 cc/kg of Ringer lactate followed by 5 mg/kg of Furosemide; however, he passed only 4.5 ml of urine. Thus he was diagnosed as acute renal failure. His S.Creatinine was 6.7 mg/dl; serum potassium was 6.7 meq/dl with blood gases suggestive of pH of 6.78 with bicarbonate of 3 meq/L. His ultrasound of abdomen showed Right kidney of 5.4 x 3 cm and left kidney of 4.6 x 2.7 cm with normal echotexture and no loss of CMD. In view of his ARF, he underwent peritoneal dialysis and S.Creatinine fell to 3.8 mg/dl with serum potassium of 4.6 meq/L and pH of 7.3 with bicarbonate of 20 meq/L and he started passing urine spontaneously after 36 hours of peritoneal dialysis. In view of high WBC count of 27, 700 cells/cumm (70% polymorphs, 30% lymphocytes) and positive CRP, he was treated with IV cefoperazone and IV Imipenam for 14 days and discharged on oral bicarbonate supplement, calcium and iron supplement.

On Day 21 of life, he was readmitted with cellulitis of right forearm for which he was treated with IV Piperacillin and Ceftizoxime and required a fasciotomy. He was investigated for immunodeficiency and his S.immunoglobulins were suggestive of Hyper IgM syndrome. [Serum IgG <260 mg/dl, serum IgA = 20 mg/dl and serum IgM = 170 mg/dl] in view of low serum IgG & IgA and increased IgM. His CD40 ligand could not be done due to unavailability of the facility. On follow-up his renal parameters are normal and there are no further episodes of infections.

Discussion


Hyper IgM syndrome is a congenital immunodeficiency that is due to a predominant primary defect of antibody production. Hyper IgM syndrome is genetically heterogeneous. It may be due to 2 genetic mutations on the X chromosome, the CD40 ligand and NEMOgenes or due to 2 genetic mutations on autosomal chromosomes.

X-linked Hyper IgM due to mutation in the CD40 ligand gene is seen in boys and is clinically similar to X-linked agammaglobulinemia. Patients have small tonsils, often no palpable lymphnodes and become symptomatic during the 1st or 2nd year of life with recurrent pyogenic infections. These patients have marked susceptibility to P.carinii pneumonia and are often profoundly neutropenic. There is increased incidence of extensive verruca vulgaris, cryptosporidium enteritis, subsequent liver disease and increased risk of malignancy. Patients have very low serum concentrations of IgG and IgA with normal or elevated concentration of polyclonal IgM. They have normal number of circulating B & T cells. It has a poor prognosis.

X-linked Hyper-IgM due to mutations in NEMOgene is clinically characterized by anhidrotic ectodermal dysplasia. It leads to X-linked dominant incontinentia of pigmenti in females and is lethal in males.

Patients with autosomal Hyper IgM due to ALD mutation present much later in life and do not have susceptibility to P.carinii pneumonia. They have very low concentration of serum IgG, IgA and IgE and markedly elevated IgM. This condition is more benign as compared to boys with CD40 ligand defect.

Patients with autosomal recessive Hyper IgM due to mutations in CD40 are clinically indistinguishable from those with X-linked CD40 ligand defect.

Treatment consists of monthly infusion of IVIg and management of infections with antibiotics. For X-linked CD40 ligand defect early bone marrow transplant is the treatment of choice and prophylaxis for PCP is recommended.

References


  1. Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics, 17th ed. W.B. Saunders, Philadelphia, 2004:691-693
Last Updated on 01-08-2004

How to cite this url

Shah I.Hyper IGM With Recurrent Neonatal Infections.Pediatric Oncall [serial online] 2004 [cited 2004 August 1];1. Available from:
http://www.pediatriconcall.com/fordoctor/casereports/hyper_igm.asp
 
  Grants  
 » Apply For Research Grant
  Search  
Hospitals
Pediatrician
Special Schools
Medical Colleges
Pediatric Residency
Pediatric Conferences
Jobs & Vacancies
Journals
NGO's
  Ped Tools  
Pediatric Calculator
Drug Index
Medical Equipment
Vaccine Reminder
Adverse Drug Reactions
Biochemical Profile
Online MCQ's
  Calculators  
+ Growth
+ Conversion
+ Renal
+ Pregnancy
+ Blood Pressure
+ Blood Group
+ Critical Care
+ Drug Dose
+ Diarrhea Solution
+ Reference Values
+ Antibody Test
+ Drug Interaction
 
 
Parent Corner l Kids Corner l Terms & Condition l Privacy Statement | Advertising l Feedback | Awards
Newsletter | About Us l Link to Us l Site Map l Shopping Mall l Media Room  
Partner Sites
 HIV in Children  Infection in Children  Pedcall  Medical ADRIS  Vaccine Reminder  Pediatric Oncall Journal
Health Solutions from our sponsors
 Surfactant  Diarrhea  Nutrition      

Copyright© 2000-2008 All rights reserved with Pediatric Oncall

Disclaimer:The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitue an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.

 
Sitemap For Doctor | Sitemap For Parent | Sitemap For Kids Site designed and maintained by Levioza